Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.13 (
protein kinase C
)
49,245
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The vascular effects of
endothelin-1
(
ET-1
) were compared with those elicited by phorbol 12,13-dibutyrate (PDB), an activator of the
protein kinase C
(
PKC
), to analyze the involvement of this enzyme on
ET-1
responses. PDB and
ET-1
caused slow-developing contractions (sustained and transient, respectively), which were reduced by the
PKC
inhibitor, staurosporine (1 and 10 nM). Only the contractile effects evoked by
ET-1
were reduced in Ca-free medium and by the Ca channel antagonist, nifedipine (1 microM), and increased by the Ca channel agonist, BAY K 8644 (10 nM). PDB (10 and 30 nM) preincubation reduced the vasoconstriction elicited by 5-hydroxytryptamine (5-HT; 0.01, 0.1 and 1 microM) in a way dependent on phorbol concentration and preincubation time, whereas
ET-1
(1 nM) increased the contractile response to 5-HT (0.1 microM). Furthermore, PDB (0.1 microM) also reduced the responses elicited by
ET-1
(30 microM) and vice versa.
ET-1
(0.1 microM) induced transient translocation of
PKC
activity from the cytosol to the membrane, which was less than that produced by PDB (0.1 microM). Electrical stimulation induced [3H]noradrenaline (NA) release, which was increased by PDB (10 and 100 nM) and not affected by
ET-1
(10 nM). These results indicate: (1) the responses induced by PDB and
ET-1
were independent and dependent on extracellular Ca, respectively; (2)
PKC
is involved in NA release and 5-HT responses, but mainly in desensitization of these responses, and (3)
PKC
is activated by
ET-1
and is implicated in vascular actions of
ET-1
, but other mechanisms, such as the activation of
ET-1
receptors and opening of dihydropyridine-sensitive Ca channels also appear to be involved.
...
PMID:Comparison of the vasoconstrictor responses induced by endothelin and phorbol 12,13-dibutyrate in bovine cerebral arteries. 128 69
This study investigated the cellular mechanisms underlying the
endothelin-1
(
ET-1
)-induced contraction of rat aorta with focus on the involvement of phospholipase D (PLD). Preincubating rat aorta in Ca(2+)-free solution reduced the contraction by 80%, whereas diltiazem (10 microM), a voltage-operated Ca2+ channel blocker, caused only a small reduction (27%, P less than 0.05) of the contraction. In myo-[3H]inositol-labeled aorta,
ET-1
stimulated the formation of [3H]inositol bisphosphate and [3H]inositol trisphosphate, indicating the activation of phospholipase C (PLC). In aorta labeled with 32PO4, [3H] myristic acid or [32P]lyso-platelet-activating factor followed by exposure to ethanol (0.5%),
ET-1
stimulated phosphatidylethanol (PEt) production, suggesting that
ET-1
activates PLD. The PEt response was not attenuated by staurosporine (ST, 0.1 microM), an inhibitor of
protein kinase C
(
PKC
) but was inhibited by removal of Ca2+. The
ET-1
-induced PEt response was at least additive to that induced by phorbol 12-myristate 13-acetate (1 microM).
ET-1
also stimulated the release of 6-ketoprostaglandin F1 alpha (6-keto-PGF1 alpha) into the tissue medium. Unlike the PEt responses, the 6-keto-PGF1 alpha response could be inhibited by ST. Removal of Ca2+ abolished the response. These results suggest that 1)
ET-1
activates multiple cellular mechanisms including PLC, PLD, and the arachidonate cascade; 2)
PKC
activation may not be essential for the
ET-1
activation of PLD but may play an important role in the
ET-1
stimulation of 6-keto-PGF1 alpha release; and 3) Ca2+ is an important factor in the
ET-1
-induced PLD activity and 6-keto-PGF1 alpha release.
...
PMID:Activation of multiple mechanisms including phospholipase D by endothelin-1 in rat aorta. 131 92
We carried out experiments designed to investigate the effects of sarafotoxin-6B (SFTx) on [Ca2+]i in cerebellar astrocytes using the Ca2+ indicator fura-2. Both
endothelin-1
and sarafotoxin-6B increased [Ca2+]i in individual cerebellar astrocytes in cell culture. The shape of the response was variable but usually consisted of an initial peak of [Ca2+]i followed by an extended plateau increase in [Ca2+]i. In Ca(2+)-free medium only the initial peak was observed. If Ca2+ was subsequently readmitted to the external medium a plateau was now formed. When external Ca2+ was removed during a plateau, [Ca2+]i rapidly declined; replacing the external Ca2+ reversed this decline. The plateau was also reversibly reduced by addition of Ni2+ (5 mM) to the external medium. Addition of 50 mM K+ produced a small increase in [Ca2+]i in most cells. This response was blocked by nimodipine. However, nimodipine only slightly blocked the plateau increase in [Ca2+]i that was formed following activation of endothelin receptors. Furthermore, perfusion of cells with 50 mM K+ during the plateau portion of a response to SFTx reduced [Ca2+]i. In some cells addition of a phorbol ester produced a sustained increase in [Ca2+]i that was blocked by nimodipine. In conclusion, activation of endothelin receptors by SFTx in cerebellar astrocytes produces both Ca2+ mobilization and Ca2+ influx. The pathway for Ca2+ influx is predominantly a non-voltage-dependent one, although some entry through a dihydropyridine-sensitive pathway also appears to occur. Furthermore, activation of
protein kinase C
in cerebellar astrocytes activates voltage-sensitive Ca2+ channels.
...
PMID:Activation of endothelin receptors by sarafotoxin regulates Ca2+ homeostasis in cerebellar astrocytes. 131 73
This study was designed to investigate the mechanism of
endothelin-1
(
ET-1
) contractions in Staphylococcus alpha-toxin-permeabilized vascular smooth muscle. Rabbit small mesenteric arteries permeabilized with alpha-toxin were mounted for isometric or isotonic force recording or were processed for determination of myosin light chain (MLC) phosphorylation levels. Addition of 100 nM
ET-1
plus 10 microM GTP significantly enhanced myofilament Ca2+ sensitivity as compared with the addition of Ca2+ alone (EC50, 0.47 microM Ca2+ for Ca2+ alone and 0.13 microM Ca2+ for
ET-1
plus (GTP). This enhanced sensitivity was reversed by GDP beta S.
ET-1
-induced contractions were relaxed at a constant [Ca2+] by the addition of 30 microM cAMP or cGMP, demonstrating a direct effect of the cyclic nucleotides on contractile regulation. Inhibition of
protein kinase C
activity by 100 nM staurosporine relaxed
ET-1
plus GTP-induced contractions, and pretreatment with 40 microM chelerythrine inhibited the
ET-1
plus GTP increase in force. At 0.32 microM Ca2+, steady-state levels of shortening velocity were not increased by
ET-1
plus GTP, although steady-state levels of MLC phosphorylation were significantly enhanced. The
ET-1
-induced increase in MLC phosphorylation was not altered by changes in [Ca2+], whereas the shortening velocity was Ca2+ dependent, suggesting that the increase MLC phosphorylation level may be the result of
protein kinase C
, rather than MLC kinase, activation. These results are consistent with the hypothesis that
ET-1
increases myofilament Ca2+ sensitivity by a G protein-dependent pathway and subsequent activation of
protein kinase C
.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Endothelin increases myofilament Ca2+ sensitivity in alpha-toxin-permeabilized rabbit mesenteric artery. 132 99
In rat aorta
endothelin-1
(10(-8) M) induces significant increases in inositol 1,4,5-trisphosphate (IP3) levels after a 30 s exposure. An increase in particulate
protein kinase C
activity is also observed at 30 s with a second peak of activity occurring after 10 min. Flosequinan, at concentrations of 10(-6) M or greater, inhibits these
endothelin-1
-induced changes in both IP3 and particulate
protein kinase C
activity in the absence of changes in either cyclic GMP or cyclic AMP. It is likely therefore that flosequinan inhibits the transduction mechanisms between the endothelin-1 receptor and hydrolysis of phosphatidylinositol 4,5-bisphosphate, possibly at the level of a G-protein. These results provide a mechanism to explain the vasodilator effects of flosequinan observed in vitro.
...
PMID:The effects of flosequinan on endothelin-1-induced changes in inositol 1,4,5-trisphosphate levels and protein kinase C activity in rat aorta. 133 Jun 33
The present study was designed to test two hypotheses: (1) that angiotensin II (Ang II) stimulates
endothelin-1
secretion in cultured rat mesangial cells and (2) that atrial and brain natriuretic peptides (ANP and BNP) inhibit the above-mentioned secretion in these cells. Ang II stimulated immunoreactive (ir)
endothelin-1
secretion in a concentration-dependent manner between 10(-8) M and 10(-7) M. The
protein kinase C
(
PKC
) inhibitors from two chemical classes, H7 and staurosporine, inhibited secretion following such stimulation. The stimulatory effect of Ang II was also abolished in the
PKC
-depleted cells. Rat ANP(1-28) and rat BNP-45, which are the respective major circulating forms of ANP and BNP in rats, potently inhibited Ang II-stimulated
endothelin-1
secretion in a concentration-dependent manner. Inhibition by ANP and BNP of Ang II-stimulated
endothelin-1
secretion was paralleled by an increase in the cellular level of cyclic guanosine 5'-monophosphate (GMP). The addition of a cyclic GMP analogue, 8-bromo cyclic GMP, reduced the stimulated
endothelin-1
secretion. Rat ANP(5-25) was less effective that rat ANP(1-28) with respect to inhibiting ir-
endothelin-1
secretion and increasing cellular cyclic GMP. These findings indicate that Ang II stimulates
endothelin-1
secretion in cultured rat mesangial cells by a mechanism probably involving activation of
PKC
, and that rat ANP and BNP inhibit this stimulated secretion through a cyclic GMP-dependent process.
...
PMID:Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells. 133 47
Phosphoinositide hydrolysis was studied in primary cultures of rat cerebellar astrocytes prelabeled with [3H]myo-inositol. Among the agonists examined, the rank order of efficacies in causing phosphoinositide hydrolysis was bradykinin >
endothelin-1
> ATP > norepinephrine. The bradykinin response was robust (24-fold increase) with EC50 value of 30 nM and saturating concentration of 1 microM. Preincubation of cells with pertussis toxin did not affect the activation of phosphoinositide turnover by bradykinin. Although short-term (within 90 min) treatment of cells with phorbol dibutyrate attenuated bradykinin-induced phosphoinositide breakdown, the inhibitory effect was lost after 3-6 h of phorbol dibutyrate treatment. Extended (24 h) preincubation resulted in a potentiation of bradykinin response. Homologous desensitization of bradykinin response was observed in cells prestimulated with bradykinin for up to 6 h. However, similar to the effect of phorbol dibutyrate, 24-h pretreatment with bradykinin selectively sensitized the response to bradykinin. Up-regulation of the bradykinin response was also observed in cells prestimulated with
endothelin-1
or norepinephrine for 24 h, although these treatments resulted in only homologous desensitization to their own response. Our results suggest that cultured cerebellar astrocytes express bradykinin receptors coupled to phospholipase C and in these cells
protein kinase C
plays a more prominent role in the negative-feedback regulation of bradykinin-evoked phosphoinositide response.
...
PMID:Regulation of bradykinin-induced phosphoinositide turnover in cultured cerebellar astrocytes: possible role of protein kinase C. 133 44
In the last decade a great deal of attention was awarded to a signal transduction pathway which is utilized primarily by 'Ca2+ mobilizing' signal molecules and which involves the hydrolysis of a quantitatively minor phospholipid, phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) by a PtdIns-specific phospholipase C (PLC). The evidence for the existence of receptor-mediated GTP binding protein-coupled PLC in myocardium and its possible functions are briefly summarized. The minireview is concentrated on the following aspects: 1) cellular localization and synthesis of polyphospho-PtdIns from PtdIns, 2) desensitization of the alpha 1-adrenergic agonist and
endothelin-1
mediated PtdIns responses, 3) oscillatory Ca2+ transients initiated by PtdIns(4,5)P2 hydrolysis, 4) polyunsaturated fatty acids as constituents of polyphospho-PtdIns and of the
protein kinase C
activator 1,2-diacylglycerol (DAG), 5) source other than PtdIns(4,5)P2 contributing to the stimulated DAG, 6) role of the PtdIns pathway in cardiomyocyte growth and gene expression during the hypertrophic response.
...
PMID:Occurrence and functions of the phosphatidylinositol cycle in the myocardium. 136 47
1. Calphostin C at 10(-6) M was shown to be selective and highly effective in inhibiting contractile responses of rat aortae to 12-o-tetradecanoylphorbol-13-acetate, while it had no effect on contractile responses to elevated KCl. 2. In the rat aorta,
endothelin-1
(
ET-1
) developed a sustained tonic contraction dose-dependently in both normal Ca(2+)-containing Krebs and Ca(2+)-free Krebs containing 1 mM EGTA. Calphostin C (10(-6) M), a selective protein kinase C inhibitor, antagonized the maximal tensions for cumulative addition of 10(-8) M
ET-1
by 13.2% in Ca(2+)-containing medium and 25.8% in Ca(2+)-free Krebs containing 1 mM EGTA. 3. In both Ca(2+)-containing medium and Ca(2+)-free Krebs containing 1 mM EGTA, precontraction with 10(-8) M
ET-1
had no effects on the contractile response to subsequently added 10(-6) M 12-o-tetradecanoylphorbol-13-acetate (TPA), an activator of
protein kinase C
. 4. In Ca(2+)-free Krebs containing 1 mM EGTA, precontraction with 10(-6) M TPA potentiated the contractile response to subsequently added 10(-8) M
ET-1
, whereas this potentiation was abolished by pretreatment with 10(-6) M calphostin C. The mechanism of the TPA-induced potentiating effect remains to be determined. 5. These results suggest that the participation of
protein kinase C
in the 10(-8) M
ET-1
-induced contraction may be 13.2% and 25.8% in the presence and absence of extracellular Ca2+, respectively, and that mechanisms other than
protein kinase C
may be predominantly responsible for
ET-1
-induced tonic contraction.
...
PMID:Participation of protein kinase C in endothelin-1-induced contraction in rat aorta: studies with a new tool, calphostin C. 138 8
The N-methyl-D-aspartate (NMDA) receptor of rat cerebellar granule cells in primary culture is inhibited by phospholipase C-coupled receptor activation. In the absence of ionotropic agonist, cells modulate their cytoplasmic free Ca2+, [Ca2+]c, in response to stimulation of M3 muscarinic receptors, metabotropic glutamate receptors, and endothelin receptors by the respective agonists carbachol, trans-1-amino-1,3-cyclopentanedicarboxylic acid, and
endothelin-1
. The response is consistent with the ability of phospholipase C-coupled receptors to release a pool of intracellular Ca2+ and induce a subsequent Ca2+ entry into the cell; both of these responses can be abolished by discharge of internal Ca2+ stores with low concentrations of ionomycin or thapsigargin. In the case of cells stimulated with NMDA, the [Ca2+]c response to the phospholipase C-coupled agonists is complex and agonist dependent; however, in the presence of ionomycin each agonist produces a partial inhibition of the NMDA component of the [Ca2+]c signal. This inhibition can be mimicked by the
protein kinase C
activator 4 beta-phorbol 12,13-dibutyrate. It is concluded that NMDA receptors on cerebellar granule cells are inhibited by phospholipase C-coupled muscarinic M3, glutamatergic, and endothelin receptors via activation of
protein kinase C
.
...
PMID:Interactions between phospholipase C-coupled and N-methyl-D-aspartate receptors in cultured cerebellar granule cells: protein kinase C mediated inhibition of N-methyl-D-aspartate responses. 138 23
1
2
3
4
5
6
7
8
9
10
Next >>